Circulatory monitoring systems and methods
View Patent ↗Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. Some involve implementing or deploying therapeutic administration systems, for example, for obtaining a flow-change-indicative measurement and signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement.
1. A therapeutic administration system comprising:
a first dispenser operable for dispensing at least a clot-reducing agent;
circuitry for obtaining a flow-change-indicative measurement;
circuitry for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement;
a second dispenser operable for targeting an implant site; and
a wireless-communication device operable for communicating a selection of at least one of the first dispenser or the second dispenser.
2. The therapeutic administration system of claim 1 in which the circuitry for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprises:
circuitry for deciding upon at least one of the one or more clot-reducing agents in response to obtaining an anomalous values as the flow-change-indicative measurement.
3. The therapeutic administration system of claim 1 in which the circuitry for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprises:
circuitry for causing one or more dispensations in response to an apparent problem in the flow-change-indicative measurement.
4. The therapeutic administration system of claim 1 in which the circuitry for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprises:
circuitry for deciding upon at least one of the one or more clot-reducing agents in response to obtaining an anomalous value as the flow-change-indicative measurement;
circuitry for signaling at least an anticoagulant in response to an apparent flow degradation, the anticoagulant being one of the one or more clot-reducing agents; and
circuitry for causing one or more dispensations in response to an apparent problem in the flow-change-indicative measurement.
5. A method of using the therapeutic administration system of claim 1 comprising:
providing the flow-change-indicative measurement to the circuitry for signaling the decision whether to administer the one or more clot-reducing agents at least partly based on the flow-change-indicative measurement; and
receiving the decision whether to administer the one or more clot-reducing agents at least partly based on the flow-change-indicative measurement from the circuitry for signaling the decision whether to administer the one or more clot-reducing agents at least partly based on the flow-change-indicative measurement.
6. A therapeutic administration system comprising:
a first dispenser operable for dispensing at least a lytic material;
circuitry for signaling a decision whether or not to administer one or more clot-reducing agents at least partly based on a flow-change-indicative measurement, the lytic material being one of the one or more clot-reducing agents;
a second dispenser operable for targeting an implant site; and
a wireless-communication device operable for communicating a selection of at least one of the first dispenser or the second dispenser.
7. The therapeutic administration system of claim 6 in which the circuitry for signaling a decision whether or not to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprises:
circuitry for deciding upon at least one of the one or more clot-reducing agents as a conditional response to obtaining an anomalous valve as the flow-change-indicative measurement.
8. The therapeutic administration system of claim 6 in which the circuitry for signaling a decision whether or not to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprises:
circuitry for causing one or more dispensations of the one or more clot reducing agents as a conditional response to an apparent problem in the flow-change-indicative measurement.
9. The therapeutic administration system of claim 6 , further comprising:
circuitry for obtaining the flow-change-indicative measurement comprising a flow-force-responsive element.
10. The therapeutic administration system of claim 6 , further comprising:
circuitry for obtaining the flow-change-indicative measurement comprising a reflectance sensor.
11. The therapeutic administration system of claim 6 , further comprising:
circuitry for obtaining the flow-change-indicative measurement comprising an ion sensor.
12. The therapeutic administration system of claim 6 in which the second dispenser comprises:
a thrombolytic-agent-containing dispenser responsive to the decision whether or not to administer the one or more clot-reducing agents operable for targeting an implant site.
13. The therapeutic administration system of claim 6 in which the second dispenser comprises:
an implant-site-targeting dispenser responsive to the decision whether or not to administer the one or more clot-reducing agents at least partly based on the flow-change-indicative measurement.
14. A therapeutic administration system comprising:
a first dispenser operable for dispensing at least a lytic material;
circuitry for obtaining a flow-change-indicative measurement;
circuitry for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement, including:
(1) one or more of a flow-force-responsive element, an optical sensor, or an auditory sensor;
(2) circuitry for deciding upon at least one of the one or more clot-reducing agents in response to obtaining an anomalous value as the flow-change-indicative measurement;
(3) circuitry for causing one or more dispensations in response to an apparent problem in the flow-change-indicative measurement;
(4) circuitry for signaling an anticoagulant in response to an apparent flow degradation, the anticoagulant being one of the one or more clot-reducing agents;
a second dispenser operable for targeting an implant site; and
a wireless-communication device operable for communicating a selection of at least one of the first dispenser or the second dispenser.
15. The therapeutic administration system of claim 14 in which the circuitry for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprises:
one or more sensors configured to obtain the flow-change-indicative measurement, the one or more sensors including at least one of a reflectance sensor or a transmittance sensor.
16. The therapeutic administration system of claim 14 in which the circuitry for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprises:
one or more sensors configured to obtain the flow-change-indicative measurement, the one or more sensors including at least one of a sonic sensor or an ion sensor.